Subscribe To

Price Alert Latest News Economic Calendar News

TRIB / Trinity Biotech shares jump 6% premarket after WHO approves is rapid test for HIV

Dublin-based Trinity Biotech Plc shares TRIB, -4.24% jumped 6% premarket Monday, after the company said it has received approval from the World Health Organization for its HIV screening product, TrinScreen. The company's Uni-Gold HIV product has served as the main confirmatory test for the detection of HIV in Africa for many years. Read More

Demo Live Account See Partner Details

Content Topics

China

Zheshang

Bank

Co

Ltd

601916

Ss

Trinity

Biotech

Premarket

Approves

Stock

TRIB

Posted: Feb 14 2022, 08:31

Author Name: Market Watch

TRIB News

By GlobeNewsWire
September 27, 2023

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results

DUBLIN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the poi

By GlobeNewsWire
July 3, 2023

Trinity Biotech plc to Announce First Quarter Fiscal Year 2023 Financial Results

DUBLIN, July 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the poin

By GlobeNewsWire
March 16, 2023

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2022 Financial Results

Conference Call Scheduled for March 23, 2023 at 10:00 am EASTERN Conference Call Scheduled for March 23, 2023 at 10:00 am EASTERN

By Seeking Alpha
December 15, 2022

Trinity Biotech plc (TRIB) Q3 2022 Earnings Call Transcript

Trinity Biotech plc (NASDAQ:TRIB ) Q3 2022 Earnings Conference Call December 15, 2022 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR

By Seeking Alpha
November 5, 2022

Trinity Biotech plc (TRIB) Q2 2022 Earnings Call Transcript

Trinity Biotech plc (NASDAQ:TRIB ) Q2 2022 Results Conference Call November 3, 2022 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Ar

By Seeking Alpha
June 30, 2022

Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q1 2022 Results - Earnings Call Transcript

Trinity Biotech plc (NASDAQ:TRIB ) Q1 2022 Earnings Conference Call June 30, 2022 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Rona

By GlobeNewsWire
June 29, 2022

Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results

Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN

By Benzinga
April 11, 2022

Trinity Biotech Stock Surges After $45M Capital Infusion From Korea-Based Firm

Trinity Biotech plc (NASDAQ: TRIB) announced a $45 million investment and partnership with MiCo Ltd, a KOSDAQ-listed and Korea-based company. MiCo

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.